About: Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care
Creator	Bansal, Mehak Deep, Akash Purif, Blood Ricci, Zaccaria Bansal, Deep Ricci, /
Source	Medline; PMC
abstract	Children seem to be less severely affected by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) as compared to adults. Little is known about the prevalence and pathogenesis of acute kidney injury (AKI) in children affected by SARS-CoV-2. Dehydration seems to be the most common trigger factor, and meticulous attention to fluid status is imperative. The principles of initiation, prescription, and complications related to renal replacement therapy are the same for coronavirus disease (COVID) patients as for non-COVID patients. Continuous renal replacement therapy (CRRT) remains the most common modality of treatment. When to initiate and what modality to use are dependent on the available resources. Though children are less often and less severely affected, diversion of all hospital resources to manage the adult surge might lead to limited CRRT resources. We describe how these shortages might be mitigated. Where machines are limited, one CRRT machine can be used for multiple patients, providing a limited number of hours of CRRT per day. In this case, increased exchange rates can be used to compensate for the decreased duration of CRRT. If consumables are limited, lower doses of CRRT (15–20 mL/kg/h) for 24 h may be feasible. Hypercoagulability leading to frequent filter clotting is an important issue in these children. Increased doses of unfractionated heparin, combination of heparin and regional citrate anticoagulation, or combination of prostacyclin and heparin might be used. If infusion pumps to deliver anticoagulants are limited, the administration of low-molecular-weight heparin might be considered. Alternatively in children, acute peritoneal dialysis can successfully control both fluid and metabolic disturbances. Intermittent hemodialysis can also be used in patients who are hemodynamically stable. The keys to successfully managing pediatric AKI in a pandemic are flexible use of resources, good understanding of dialysis techniques, and teamwork.
has issue date	2020-07-14(xsd:dateTime)
bibo:doi	10.1159/000509677
bibo:pmid	32663827
has license	no-cc
sha1sum (hex)	e0b85efb7534421aacd3f4ebbbad4cbdbaabe262
schema:url	https://doi.org/10.1159/000509677
resource representing a document's title	Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care
has PubMed Central identifier	PMC7445370
has PubMed identifier	32663827
schema:publication	Blood Purif
resource representing a document's body	covid:e0b85efb7534421aacd3f4ebbbad4cbdbaabe262#body_text
is schema:about of	named entity 'limited' named entity 'limited' named entity 'fluid' named entity 'manage' named entity 'heparin' named entity 'limited' named entity 'common' named entity 'patients' named entity 'disease' named entity 'hemodialysis' named entity 'combination' named entity 'renal replacement therapy' named entity 'limited' named entity 'initiate' named entity 'Neonatal Intensive Care' named entity 'Coronavirus' named entity 'EXCHANGE RATES' named entity 'COMPENSATE' named entity 'DECREASED DURATION' named entity 'ACUTE' named entity 'LOWER' named entity 'INTERMITTENT HEMODIALYSIS' named entity 'CORONAVIRUS DISEASE' named entity 'Dehydration' named entity 'leading' named entity 'coronavirus' named entity 'modality' named entity 'frequent' named entity 'compensate' named entity 'fluid' named entity 'SARS-CoV-2' named entity 'acute' named entity 'Where' named entity 'AKI' named entity 'multiple' named entity 'mitigated' named entity 'Continuous' named entity 'citrate' named entity 'COVID' named entity 'citrate' named entity 'CRRT' named entity 'Hypercoagulability' named entity 'CRRT' named entity 'unfractionated heparin' named entity 'Dehydration' named entity 'hemodynamically' named entity 'pathogenesis' named entity 'Critical Care' named entity 'complications' named entity 'organ damage' named entity 'health care systems' named entity 'fluid overload' named entity 'AKI' named entity 'CRRT' named entity 'saline' named entity 'AKI' named entity 'renal replacement therapy' named entity 'IHD' named entity 'SARS-CoV-2' named entity 'dialysis' named entity 'COVID' named entity 'AKI' named entity 'SARS-CoV-2' named entity 'Lancet' named entity 'comorbidities' named entity 'Sodium' named entity 'patient care' named entity 'nephrology' named entity 'blood flow' named entity 'epidemiology' named entity 'anticoagulation' named entity 'citrate' named entity 'hydroxychloroquine' named entity 'COVID' named entity 'PPE' named entity 'isolation room'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software